1.Application of custom-made joint prostheses in wrist.
Xiaodi ZOU ; Yanzhao DONG ; Changxing WANG ; Hui LU
Journal of Zhejiang University. Science. B 2025;26(2):200-202
The wrist joint is a highly mobile functional joint. Wrist conditions including traumatic and degenerative arthritis, rheumatoid arthritis, and giant cell tumors of the distal radius, cause significant pain and mobility impairment. In joint surgery, the decision to use joint prostheses to reconstruct joint function is greatly influenced by the characteristics of the prosthesis (Mok et al., 2016). However, traditional implants have limitations such as shape mismatch, inadequate implant-bone interface strength which causes loosening, and poor bone ingrowth (Zhang et al., 2014).
Humans
;
Joint Prosthesis
;
Wrist Joint/surgery*
;
Prosthesis Design
;
Arthroplasty, Replacement
;
Arthritis, Rheumatoid/surgery*
2.COVID-19 and acute limb ischemia: latest hypotheses of pathophysiology and molecular mechanisms.
Chengjun YAO ; Yanzhao DONG ; Haiying ZHOU ; Xiaodi ZOU ; Ahmad ALHASKAWI ; Sohaib Hasan Abdullah EZZI ; Zewei WANG ; Jingtian LAI ; Vishnu Goutham KOTA ; Mohamed Hasan Abdulla Hasan ABDULLA ; Zhenfeng LIU ; Sahar Ahmed ABDALBARY ; Olga ALENIKOVA ; Hui LU
Journal of Zhejiang University. Science. B 2025;26(4):333-352
Coronavirus disease 2019 (COVID-19) is a multi-system disease that can lead to various severe complications. Acute limb ischemia (ALI) has been increasingly recognized as a COVID-19-associated complication that often predicts a poor prognosis. However, the pathophysiology and molecular mechanisms underlying COVID-19-associated ALI remain poorly understood. Hypercoagulability and thrombosis are considered important mechanisms, but we also emphasize the roles of vasospasm, hypoxia, and acidosis in the pathogenesis of the disease. The angiotensin-converting enzyme 2 (ACE2) pathway, inflammation, and platelet activation may be important molecular mechanisms underlying these pathological changes induced by COVID-19. Furthermore, we discuss the hypotheses of risk factors for COVID-19-associated ALI from genetic, age, and gender perspectives based on our analysis of molecular mechanisms. Additionally, we summarize therapeutic approaches such as use of the interleukin-6 (IL-6) blocker tocilizumab, calcium channel blockers, and angiotensin-converting enzyme inhibitors, providing insights for the future treatment of coronavirus-associated limb ischemic diseases.
Humans
;
COVID-19/physiopathology*
;
Ischemia/etiology*
;
SARS-CoV-2
;
Extremities/blood supply*
;
Risk Factors
;
Interleukin-6/antagonists & inhibitors*
;
Acute Disease
;
Angiotensin-Converting Enzyme 2

Result Analysis
Print
Save
E-mail